Dorgan Byron L 4
4 · CODEXIS, INC. · Filed Jan 21, 2021
Insider Transaction Report
Form 4
CODEXIS, INC.CDXS
Dorgan Byron L
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-20$10.63/sh+25,000$265,750→ 187,790 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-20−25,000→ 25,000 totalExercise: $10.63From: 2014-02-17Exp: 2021-02-16→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2021-01-21$10.63/sh+25,000$265,750→ 187,790 total - Sale
Common Stock
2021-01-20$26.75/sh−25,000$668,658→ 162,790 total - Sale
Common Stock
2021-01-21$25.17/sh−25,000$629,195→ 162,790 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-21−25,000→ 0 totalExercise: $10.63From: 2014-02-17Exp: 2021-02-16→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021.
- [F2]The transaction was executed in multiple trades in prices ranging from $26.46 to $27.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The transaction was executed in multiple trades in prices ranging from $24.78 to $25.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.